Annual CFI
-$35.60 K
+$65.30 K+64.72%
December 1, 2023
Summary
- As of February 7, 2025, RNAZ annual cash flow from investing activities is -$35.60 thousand, with the most recent change of +$65.30 thousand (+64.72%) on December 1, 2023.
- During the last 3 years, RNAZ annual CFI has fallen by -$35.60 thousand (-100.00%).
Performance
RNAZ Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$12.90 K
-$8300.00-180.43%
September 1, 2024
Summary
- As of February 7, 2025, RNAZ quarterly cash flow from investing activities is -$12.90 thousand, with the most recent change of -$8300.00 (-180.43%) on September 1, 2024.
- Over the past year, RNAZ quarterly CFI has dropped by -$8300.00 (-180.43%).
Performance
RNAZ Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$21.30 K
-$8300.00-63.85%
September 1, 2024
Summary
- As of February 7, 2025, RNAZ TTM cash flow from investing activities is -$21.30 thousand, with the most recent change of -$8300.00 (-63.85%) on September 1, 2024.
- Over the past year, RNAZ TTM CFI has increased by +$42.50 thousand (+66.61%).
Performance
RNAZ TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
RNAZ Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +64.7% | -180.4% | +66.6% |
| 3 y3 years | -100.0% | +82.0% | +87.4% |
| 5 y5 years | - | -100.0% | -100.0% |
RNAZ Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +85.9% | <-9999.0% | +84.4% | -63.9% | +91.5% |
| 5 y | 5-year | <-9999.0% | +85.9% | <-9999.0% | +84.4% | <-9999.0% | +91.5% |
| alltime | all time | <-9999.0% | +85.9% | <-9999.0% | +84.4% | <-9999.0% | +91.5% |
TransCode Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$12.90 K(+180.4%) | -$21.30 K(+63.8%) |
| Jun 2024 | - | -$4600.00(+21.1%) | -$13.00 K(-50.9%) |
| Mar 2024 | - | -$3800.00(<-9900.0%) | -$26.50 K(-25.6%) |
| Dec 2023 | -$35.60 K(-64.7%) | $0.00(-100.0%) | -$35.60 K(-44.2%) |
| Sep 2023 | - | -$4600.00(-74.6%) | -$63.80 K(+7.8%) |
| Jun 2023 | - | -$18.10 K(+40.3%) | -$59.20 K(-28.8%) |
| Mar 2023 | - | -$12.90 K(-54.3%) | -$83.10 K(-17.6%) |
| Dec 2022 | -$100.90 K | -$28.20 K(<-9900.0%) | -$100.90 K(-35.1%) |
| Sep 2022 | - | $0.00(-100.0%) | -$155.40 K(-31.5%) |
| Jun 2022 | - | -$42.00 K(+36.8%) | -$227.00 K(+9.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$30.70 K(-62.9%) | -$207.20 K(-17.7%) |
| Dec 2021 | -$251.80 K(<-9900.0%) | -$82.70 K(+15.5%) | -$251.80 K(+48.9%) |
| Sep 2021 | - | -$71.60 K(+222.5%) | -$169.10 K(+73.4%) |
| Jun 2021 | - | -$22.20 K(-70.5%) | -$97.50 K(+29.5%) |
| Mar 2021 | - | -$75.30 K(<-9900.0%) | -$75.30 K(<-9900.0%) |
| Dec 2020 | $0.00 | - | - |
| Dec 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
FAQ
- What is TransCode Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for TransCode Therapeutics?
- What is TransCode Therapeutics annual CFI year-on-year change?
- What is TransCode Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly CFI year-on-year change?
- What is TransCode Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for TransCode Therapeutics?
- What is TransCode Therapeutics TTM CFI year-on-year change?
What is TransCode Therapeutics annual cash flow from investing activities?
The current annual CFI of RNAZ is -$35.60 K
What is the all time high annual CFI for TransCode Therapeutics?
TransCode Therapeutics all-time high annual cash flow from investing activities is $0.00
What is TransCode Therapeutics annual CFI year-on-year change?
Over the past year, RNAZ annual cash flow from investing activities has changed by +$65.30 K (+64.72%)
What is TransCode Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of RNAZ is -$12.90 K
What is the all time high quarterly CFI for TransCode Therapeutics?
TransCode Therapeutics all-time high quarterly cash flow from investing activities is $0.00
What is TransCode Therapeutics quarterly CFI year-on-year change?
Over the past year, RNAZ quarterly cash flow from investing activities has changed by -$8300.00 (-180.43%)
What is TransCode Therapeutics TTM cash flow from investing activities?
The current TTM CFI of RNAZ is -$21.30 K
What is the all time high TTM CFI for TransCode Therapeutics?
TransCode Therapeutics all-time high TTM cash flow from investing activities is $0.00
What is TransCode Therapeutics TTM CFI year-on-year change?
Over the past year, RNAZ TTM cash flow from investing activities has changed by +$42.50 K (+66.61%)